Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' KIRSCHFINK M' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 70 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kraiczy, P; Skerka, C; Kirschfink, M; Zipfel, PF; Brade, V
      Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates

      INTERNATIONAL IMMUNOPHARMACOLOGY
    2. Schwertz, R; Rother, U; Anders, D; Gretz, N; Scharer, K; Kirschfink, M
      Complement analysis in children with idiopathic membranoproliferative glomerulonephritis: A long-term follow-up

      PEDIATRIC ALLERGY AND IMMUNOLOGY
    3. Kurjane, N; Bruvere, R; Shitova, O; Romanova, T; Jaunalksne, I; Kirschfink, M; Sochnevs, A
      Analysis of the immune status in Latvian Chernobyl clean-up workers with nononcological thyroid diseases

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    4. Kirschfink, M
      Targeting complement in therapy

      IMMUNOLOGICAL REVIEWS
    5. Tolksdorf, B; Frietsch, T; Quintel, M; Kirschfink, M; Becker, P; Lorentz, A
      Humoral immune response to autologous blood transfusion in hip surgery: whole blood versus packed red cells and plasma

      VOX SANGUINIS
    6. Frietsch, T; Fessler, H; Kirschfink, M; Nebe, T; Waschke, KF; Lorentz, A
      Immune response to autologous transfusion in healthy volunteers: WB versuspacked RBCs and FFP. (vol 41, pg 470, 2001)

      TRANSFUSION
    7. Frietsch, T; Fessler, H; Kirschfink, M; Nebe, T; Waschke, KF; Lorentz, A
      Immune response to autologous transfusion in healthy volunteers: WE versuspacked RBCs and FFP

      TRANSFUSION
    8. Lehmann, TG; Koeppel, TA; Munch, S; Heger, M; Kirschfink, M; Klar, E; Post, S
      Impact of inhibition of complement by sCR1 on hepatic microcirculation after warm ischemia

      MICROVASCULAR RESEARCH
    9. Jurianz, K; Ziegler, S; Donin, N; Reiter, Y; Fishelson, Z; Kirschfink, M
      K562 erythroleukemic cells are equipped with multiple mechanisms of resistance to lysis by complement

      INTERNATIONAL JOURNAL OF CANCER
    10. Kraiczy, P; Skerka, C; Kirschfink, M; Brade, V; Zipfel, PF
      Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1/reconectin and Factor H

      EUROPEAN JOURNAL OF IMMUNOLOGY
    11. Heller, A; Kunz, M; Samakas, A; Haase, M; Kirschfink, M; Koch, T
      The complement regulators C1 inhibitor and soluble complement receptor 1 attenuate acute lung injury in rabbits

      SHOCK
    12. Keldenich, S; Kopp, R; Kirschfink, M; Klein, B; Henseler, A; Thelen, H; Oedekoven, B; Mottaghy, K
      Application of a new dynamic flow model for investigating the biocompatibility of modified surfaces

      ASAIO JOURNAL
    13. Klima, U; Kutschka, I; Warnecke, G; Kim, P; Struber, M; Kirschfink, M; Haverich, A
      Improved right ventricular function after intracoronary administration of a C1 esterase inhibitor in a right heart transplantation models

      EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
    14. Nagy, G; Brozik, M; Varga, L; Fust, G; Kirschfink, M; Kiss, E; Gergely, P
      Usefulness of detection of complement activation products in evaluating SLE activity

      LUPUS
    15. Radke, A; Mottaghy, K; Goldmann, C; Khorram-Sefat, R; Kovacs, B; Janssen, A; Klosterhalfen, B; Hafemann, B; Pallua, N; Kirschfink, M
      C1 inhibitor prevents capillary leakage after thermal trauma

      CRITICAL CARE MEDICINE
    16. Lehmann, TG; Heger, M; Munch, S; Kirschfink, M; Klar, E
      Complement inhibition by C1-Esterase-inhibitor reduces microcirculatory disturbances after warm hepatic ischemia.

      LANGENBECKS ARCHIVES OF SURGERY
    17. Binder, R; Kress, A; Kirschfink, M
      Modulation of C5a-mediated effector functions of human polymorphonuclear leukocytes by tumor necrosis factor alpha and granulocyte macrophage colony-stimulating factor

      EXPERIMENTAL AND CLINICAL IMMUNOGENETICS
    18. Jurianz, K; Maslak, S; Garcia-Schuler, H; Fishelson, Z; Kirschfink, M
      Neutralization of complement regulatory proteins augments lysis of breast carcinoma cells targeted with rhumAb anti-HER2

      IMMUNOPHARMACOLOGY
    19. Kirschfink, M; Nurnberger, W
      C1 inhibitor in anti-inflammatory therapy: from animal experiment to clinical application

      MOLECULAR IMMUNOLOGY
    20. Binder, R; Kress, A; Kan, GZ; Herrmann, K; Kirschfink, M
      Neutrophil priming by cytokines and vitamin D binding protein (Gc-globulin): impact on C5a-mediated chemotaxis, degranulation and respiratory burst

      MOLECULAR IMMUNOLOGY
    21. Jurianz, K; Ziegler, S; Garcia-Schuler, H; Kraus, S; Bohana-Kashtan, O; Fishelson, Z; Kirschfink, M
      Complement resistance of tumor cells: Basal and induced mechanisms

      MOLECULAR IMMUNOLOGY
    22. Kerr, SR; Dalmasso, AP; Apasova, EV; Chen, SS; Kirschfink, M; Matas, AJ
      Mouse-to-rabbit xenotransplantation - A new small animal model of hyperacute rejection mediated by the classical complement pathway

      TRANSPLANTATION
    23. Protzer, U; Nassal, M; Chiang, PW; Kirschfink, M; Schaller, H
      Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    24. CHIU YY; NISIHARA RM; WURZNER R; KIRSCHFINK M; DEMESSIASREASON IJ
      SC5B-9 IS THE MOST SENSITIVE MARKER IN ASSESSING DISEASE-ACTIVITY IN BRAZILIAN SLE PATIENTS

      Journal of investigational allergology & clinical immunology
    25. PFEIFFER KA; SILLEM M; DANIEL V; KIRSCHFINK M; SUSAL C; RUNNEBAUM B; GERHARD I
      ACTIVATED AUTOLOGOUS BLOOD THERAPY IN RECURRENT SPONTANEOUS-ABORTION - RESULTS OF A PILOT-STUDY

      Human reproduction
    26. LIAN YC; DELLANEGRA M; DIOGO CL; FERRIANI V; OLIVEIRA LC; KIRSCHFINK M; GRUMACH AS
      INVOLVEMENT OF COMPLEMENT-SYSTEM IN HIV-INFECTED CHILDREN

      Molecular immunology
    27. VOGEL H; HOFMANN WJ; KIRSCHFINK M
      COMPLEMENT SYNTHESIS BY HUMAN PRIMARY HEPATOCYTES - IMPACT OF CULTURECONDITIONS AND COMPARISON TO LIVER-CELL LINES HEPG2 AND CHANG LIVER

      Molecular immunology
    28. JURIANZ K; GARCIASCHULER H; FISHELSON Z; KIRSCHFINK M
      MODULATION OF MEMBRANE-ASSOCIATED COMPLEMENT REGULATORS ON TUMOR-CELLS

      Molecular immunology
    29. DEABREU MG; KIRSCHFINK M; QUINTEL M; ALBRECHT DM
      WHITE BLOOD-CELL COUNTS AND PLASMA C3A HAVE SYNERGISTIC PREDICTIVE VALUE IN PATIENTS AT RISK FOR ACUTE RESPIRATORY-DISTRESS SYNDROME

      Critical care medicine
    30. KIRSCHFINK M; HAFERKAMP A; POMER S; CHRUPCALA M; WOSNIK A; HECKLOSTREICHER B
      COMPLEMENT AND XENOTRANSPLANTATION - STRATEGIES OF THERAPEUTIC INTERVENTION

      Zentralblatt fur Chirurgie
    31. LEHMANN TG; KOEPPEL TA; KIRSCHFINK M; GEBHARD MM; HERFARTH C; OTTO G; POST S
      COMPLEMENT INHIBITION BY SOLUBLE COMPLEMENT RECEPTOR-TYPE-1 IMPROVES MICROCIRCULATION AFTER RAT-LIVER TRANSPLANTATION

      Transplantation
    32. FRIETSCH T; FESSLER H; LORENTZ A; KIRSCHFINK M; WASCHKE KF
      EFFECT OF TRANSFUSION OF AUTOLOGOUS WHOLE-BLOOD VS. AUTOLOGOUS PACKEDRED-CELLS AND FRESH-FROZEN PLASMA ON THE IMMUNE-SYSTEM OF HEALTHY-VOLUNTEERS

      Anesthesiology
    33. KIRSCHFINK M; ROTHER K
      THE SERUM COMPLEMENT-SYSTEM

      Allergologie
    34. GRUMACH AS; DUARTE AJS; BELLINATIPIRES R; PASTORINO AC; JACOB CMA; DIOGO CL; CONDINONETO A; KIRSCHFINK M; CARNEIROSAMPAIO MMS
      BRAZILIAN REPORT ON PRIMARY IMMUNODEFICIENCIES IN CHILDREN - 166 CASES STUDIED OVER A FOLLOW-UP TIME OF 15 YEARS

      Journal of clinical immunology
    35. TERNESS P; KIRSCHFINK M; NAVOLAN D; MORODER L; SIEDLER F; DRUGARIN D; SCHNEIDER F; DUFTER C; KOHL I; WELSCHOF M; OPELZ G; ROELCKE D
      INVERSE CORRELATION BETWEEN IGG-ANTIHINGE REGION AND ANTIERYTHROCYTE AUTOANTIBODY IN CHRONIC BENIGN AND MALIGNANT COLD AGGLUTINATION

      Journal of clinical immunology
    36. KIRSCHFINK M
      CONTROLLING THE COMPLEMENT-SYSTEM IN INFLAMMATION

      Immunopharmacology
    37. LEITAO MF; VILELA MMS; RUTZ R; GRUMACH AS; CONDINONETO A; KIRSCHFINK M
      COMPLEMENT FACTOR-I DEFICIENCY IN A FAMILY WITH RECURRENT INFECTIONS

      Immunopharmacology
    38. KOTNIK V; LUZNIKBUFON T; SCHNEIDER PM; KIRSCHFINK M
      MOLECULAR, GENETIC, AND FUNCTIONAL-ANALYSIS OF HOMOZYGOUS C8 BETA-CHAIN DEFICIENCY IN 2 SIBLINGS

      Immunopharmacology
    39. KIRSCHFINK M; BLASE L; ENGELMANN S; SCHWARTZALBIEZ R
      SECRETED CHONDROITIN SULFATE PROTEOGLYCAN OF HUMAN B-CELL LINES BINDSTO THE COMPLEMENT PROTEIN C1Q AND INHIBITS COMPLEX-FORMATION OF C1

      The Journal of immunology
    40. HIDVEGI T; BERRENS L; VARGA L; MARANON F; SCHMIDT B; KIRSCHFINK M; FUST G
      COMPARATIVE-STUDY OF THE COMPLEMENT-ACTIVATING AND SPECIFIC IGE-BINDING PROPERTIES OF RAGWEED POLLEN ALLERGEN

      Clinical and experimental immunology
    41. KOVACS B; PATEL A; HERSHEY JN; DENNIS GJ; KIRSCHFINK M; TSOKOS GC
      ANTIBODIES AGAINST P53 IN SERA FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS AND OTHER RHEUMATIC DISEASES

      Arthritis and rheumatism
    42. LI YL; IDRIS MA; CORACHAN M; HAN JJ; KIRSCHFINK M; RUPPEL A
      CIRCULATING ANTIGENS IN SCHISTOSOMIASIS - DETECTION OF 31 32-KDA PROTEINS IN SERA FROM PATIENTS INFECTED WITH SCHISTOSOMA-JAPONICUM, SCHISTOSOMA-MANSONI, SCHISTOSOMA-HAEMATOBIUM, OR SCHISTOSOMA-INTERCALATUM/

      Parasitology research
    43. SCHWERTZ R; DEJONG R; GRETZ N; KIRSCHFINK M; ANDERS D; SCHARER K; VANACKER K; VERPOOTEN GA; SCHULZ W; JANSSEN J; EGLI F; KISS D; LENNERT T; MALLMANN R; WEBER JP; BACHMANN HJ; DEBUSMANN ER; OLBING J; DIPPELL J; SCHINDERA F; SCHOLLMEYER P; ZIMMERHACKL LB; BLAKER F; MULLERWIEFEL DE; BRODEHL J; KROHN HP; WINGEN AM; KEHRBERG H; BEETZ R; SCHULTEWISSERMANN H; MONNENS L; WALB D; ROTHER U; THOENES W; ASSMANN K; WALDHERR R
      OUTCOME OF IDIOPATHIC MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS IN CHILDREN

      Acta paediatrica
    44. CHRUPCALA M; POMER S; WALDHERR R; STAEHLER G; KIRSCHFINK M
      INVESTIGATION BY MEANS OF THE SOLUBLE COM PLEMENT RECEPTOR-1 OF THE EFFECT OF COMPLEMENT MODULATION ON KIDNEY XENOTRANSPLANT SURVIVAL AND KIDNEY-FUNCTION - AN EXPERIMENTAL-STUDY OF 9 TRANSPLANTATIONS FROM GUINEA-PIGS TO RATS

      Der Urologe
    45. KRANZLIN B; GRETZ N; KIRSCHFINK M; MUJAIS SK
      DIALYSIS IN RATS WITH ACUTE-RENAL-FAILURE - EVALUATION OF 3 DIFFERENTDIALYZER MEMBRANES

      Artificial organs
    46. GRUMACH AS; CAMPEAS A; DIOGO CL; RAYMUNDO MC; OLIVEIRA LC; CARNEIRO MSS; FAHRAT KC; KIRSCHFINK M
      COMPLEMENT DEFICIENCIES IN PATIENTS AFFECTED BY MENINGITIDIS CAUSED BY N-MENINGITIDIS (VOL 97, PG 402, 1996)

      Journal of allergy and clinical immunology
    47. KIRSCHFINK M; PASTORINO AC; JACOB CMA; GRUMACH AS
      IGG AND IGA SUBCLASSES AND ANTI-IGA ANTIBODIES IN 34 IGA DEFICIENT PATIENTS

      Journal of allergy and clinical immunology
    48. GRUMACH AS; CAMPEAS A; DIOGO CL; RAYMUNDO MC; OLIVEIRA LC; CARNEIRO MSS; KIRSCHFINK M
      COMPLEMENT DEFICIENCIES IN PATIENTS AFFECTED BY MENINGITIS CAUSED BY N-MENINGITIDIS

      Journal of allergy and clinical immunology
    49. HECKLOSTREICHER B; WOSNIK A; KIRSCHFINK M
      PROTECTION OF PORCINE ENDOTHELIAL-CELLS FROM COMPLEMENT-MEDIATED CYTOTOXICITY BY THE HUMAN-COMPLEMENT REGULATORS CD59, C1 INHIBITOR, AND SOLUBLE COMPLEMENT RECEPTOR-TYPE-1 - ANALYSIS IN A PIG-TO-HUMAN IN-VITROMODEL RELEVANT TO HYPERACUTE XENOGRAFT REJECTION

      Transplantation
    50. KRANZLIN B; REUSS A; GRETZ N; KIRSCHFINK M; RYAN CJ; MUJAIS SK
      RECOVERY FROM ISCHEMIC ACUTE-RENAL-FAILURE - INDEPENDENCE FROM DIALYSIS MEMBRANE TYPE

      Nephron
    51. SUSAL C; KIRSCHFINK M; KROPELIN M; DANIEL V; OPELZ G
      IDENTIFICATION OF COMPLEMENT ACTIVATION SITES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GLYCOPROTEIN GP120

      Blood
    52. HECKLOSTREICHER B; KIRSCHFINK M
      INFLUENCING THE COMPLEMENT-SYSTEM PHARMAC OLOGICALLY - A CHANCE FOR ASUCCESSFUL XENOTRANSPLANTATION

      Immunitat und Infektion
    53. KIRSCHFINK M; WIENERT T; PRADO EBD; POMER S
      ON THE IMPLICATION OF THE COMPLEMENT-SYST EM IN ACUTE REVERSIBLE RENAL CRAFT REJECTION

      Immunitat und Infektion
    54. GRUMACH AS; KIRSCHFINK M
      COMPLEMENT AND IGG SUBCLASSES IN AGAMMAGLOBULINEMIC PATIENTS

      Experimental and clinical immunogenetics
    55. HIDVEGI T; SCHMIDT B; VARGA L; DERVADERICS M; LANTOS A; GONCZI Z; BAROK J; OTOS M; KIRSCHFINK M; SPATH P; FUST G
      IN-VITRO COMPLEMENT ACTIVATION BY RAGWEED ALLERGEN EXTRACT IN THE SERA OF RAGWEED ALLERGIC AND NONALLERGIC PERSONS

      Immunology letters
    56. GRUMACH AS; BELLINATTIPIRES R; PASTORINO AC; JACOB CMA; DIOGO CL; BRANDAO AC; KIRSCHFINK M; DUARTE AJS
      PRIMARY IMMUNODEFICIENCIES IN BRAZILIAN CHILDREN

      Journal of allergy and clinical immunology
    57. PETRY F; LE DT; KIRSCHFINK M; LOOS M
      NONSENSE AND MISSENSE MUTATIONS IN THE STRUCTURAL GENES OF COMPLEMENTCOMPONENT C1Q A-CHAINS AND C-CHAINS ARE LINKED WITH 2 DIFFERENT TYPESOF COMPLETE SELECTIVE C1Q DEFICIENCIES

      The Journal of immunology
    58. HECKLOSTREICHER B; BINDER R; KIRSCHFINK M
      FUNCTIONAL-ACTIVITY OF THE MEMBRANE-ASSSOCIATED COMPLEMENT INHIBITOR CD59 IN A PIG-TO-HUMAN IN-VITRO MODEL FOR HYPERACUTE XENOGRAFT REJECTION

      Clinical and experimental immunology
    59. TERNESS P; KIRSCHFINK M; NAVOLAN D; DUFTER C; KOHL I; OPELZ G; ROELCKE D
      STRIKING INVERSE CORRELATION BETWEEN IGG ANTI-F(AB')(2) AND AUTOANTIBODY PRODUCTION IN PATIENTS WITH COLD AGGLUTINATION

      Blood
    60. KIRSCHFINK M
      PHARMACOLOGICAL INFLUENCE ON THE COMPLEME NT-SYSTEM - POSSIBILITIES AND LIMITATIONS OF AN ANTIINFLAMMATORY TREATMENT

      Deutsche Medizinische Wochenschrift
    61. KRANZLIN B; REUSS A; GRETZ N; KIRSCHFINK M; RYAN CJ; MUJAIS S
      RECOVERY FROM ISCHEMIC ACUTE-RENAL-FAILURE - INDEPENDENCE FROM DIALYSIS MEMBRANE TYPE

      Journal of the American Society of Nephrology
    62. CAVALCANTI FCB; YOKOO M; PAULA FJ; PRADO MJBA; MALHEIROS DMAC; SABBAGA E; ARAP S; MARCONDES M; KIRSCHFINK M
      ISCHEMIA-REPERFUSION CAUSES COMPLEMENT ACTIVATION (CA) AND BETA-2-INTEGRIN EXPRESSION IN CADAVERIC KIDNEY-TRANSPLANTATION

      Journal of the American Society of Nephrology
    63. KIRSCHFINK M; KNOBLAUCH K; ROELCKE D
      ACTIVATION OF COMPLEMENT BY COLD AGGLUTININS

      Infusionstherapie und Transfusionsmedizin
    64. ZILOW G; KIRSCHFINK M; ROELCKE D
      RED-CELL DESTRUCTION IN COLD AGGLUTININ DISEASE

      Infusionstherapie und Transfusionsmedizin
    65. SUSAL C; KIRSCHFINK M; KROPELIN M; DANIEL V; OPELZ G
      COMPLEMENT ACTIVATION BY RECOMBINANT HIV-1 GLYCOPROTEIN GP120

      The Journal of immunology
    66. KIRSCHFINK M
      DISORDERS OF THE COMPLEMENT-SYSTEM - CLIN ICAL AND DIAGNOSTIC ASPECTS

      Deutsche Medizinische Wochenschrift
    67. KINSCHERF R; KIRSCHFINK M; STROBEL G; WEICKER H
      INFLUENCE ON MYOADENYLATE DEAMINASE FUNCTION IN RAT SKELETAL-MUSCLE AFTER HOMOLOGOUS AND HETEROLOGOUS IMMUNIZATION WITH THE PURIFIED ENZYME

      International journal of sports medicine
    68. KIRSCHFINK M; KOVACS B; MOTTAGHY K
      EXTRACORPOREAL-CIRCULATION - IN-VIVO AND IN-VITRO ANALYSIS OF COMPLEMENT ACTIVATION BY HEPARIN-BONDED SURFACES

      Circulatory shock
    69. KIRSCHFINK M; KAN G; BINDER R; CLEVE H; GIERSCHICK P; ROTHER K
      GC-GLOBULIN (VITAMIN-D-BINDING PROTEIN) MODULATES C5A-MEDIATED BIOLOGICAL-ACTIVITY

      The Journal of immunology
    70. KIRSCHFINK M; PETRY F; KHIRWADKAR K; WIGAND R; KALTWASSER JP; LOOS M
      COMPLETE FUNCTIONAL C1Q DEFICIENCY ASSOCIATED WITH SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)

      Clinical and experimental immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/01/21 alle ore 07:32:55